Apex Biotechnology Corp Sustainability Reports

The company develops, manufactures, and markets biosensor-based medical devices and monitoring systems. Its product line focuses on home diagnostics and point-of-care clinical testing, including blood glucose, blood ketone, and uric acid meters.

Sector: Manufacturing

Country: Taiwan

Exchange: Taiwan Stock Exchange

FIGI: BBG001SB5B93

13 reports from 2016 to 2025

• Apex Biotechnology Corp 2025 Consolidated Financial Statements and Independent Auditors' Report
• Apex Biotechnology Corp 2025 Annual Report
• Apex Biotechnology Corp 2024 Sustainability Report
• Apex Biotechnology Corp 2024 Annual Report
• Apex Biotechnology Corp 2023 Sustainability Report